共 50 条
- [2] Series: Cardiovascular outcome trials for diabetes drugs Degludec and DEVOTE BRITISH JOURNAL OF DIABETES, 2021, 21 (01): : 113 - 115
- [3] Series: Cardiovascular outcome trials for diabetes drugs Lixisenatide and ELIXA BRITISH JOURNAL OF DIABETES, 2020, 20 (01): : 52 - 54
- [4] Series: Cardiovascular outcome trials for diabetes drugs Liraglutide and LEADER BRITISH JOURNAL OF DIABETES, 2020, 20 (02): : 142 - 144
- [5] Series: Cardiovascular outcome trials for diabetes drugs Alogliptin and EXAMINE BRITISH JOURNAL OF DIABETES, 2019, 19 (02): : 133 - 135
- [6] Series: Cardiovascular outcome trials for diabetes drugs Sitagliptin and TECOS BRITISH JOURNAL OF DIABETES, 2020, 20 (01): : 55 - 57
- [8] Series: Cardiovascular outcome trials for diabetes drugs. CARMELINA and CAROLINA BRITISH JOURNAL OF DIABETES, 2022, 22 (01): : 42 - 46
- [9] Series: Cardiovascular outcome trials for diabetes drugs Empagliflozin and EMPA-REG OUTCOME BRITISH JOURNAL OF DIABETES, 2020, 20 (02): : 138 - 141
- [10] Series: Cardiovascular outcome trials for diabetes drugs Semaglutide and SUSTAIN-6 BRITISH JOURNAL OF DIABETES, 2021, 21 (01): : 110 - 112